Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
25.82
+2.03 (8.53%)
Dec 20, 2024, 4:00 PM EST - Market closed
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $136.27 million as of December 20, 2024. Its market cap has increased by 2,416.19% in one year.
Market Cap
136.27M
Enterprise Value
130.25M
1-Year Change
2,416.19%
Ranking
Category
Stock Price
$25.82
Market Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has decreased from $276.16M to $136.27M, a decrease of -50.65%. That is a compound annual growth rate of -13.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 136.27M | 2,594.44% |
| Dec 29, 2023 | 5.06M | -83.48% |
| Dec 30, 2022 | 30.62M | -24.23% |
| Dec 31, 2021 | 40.42M | -42.33% |
| Dec 31, 2020 | 70.09M | -59.48% |
| Dec 31, 2019 | 172.99M | -37.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Achieve Life Sciences | 131.37M |
| Instil Bio | 131.04M |
| Protalix BioTherapeutics | 128.12M |
| Akoya Biosciences | 126.39M |
| Galectin Therapeutics | 125.52M |
| InflaRx | 125.42M |
| Enanta Pharmaceuticals | 124.20M |
| Black Diamond Therapeutics | 123.92M |